EOS SENOLYTI Trademark

Trademark Overview


On Monday, December 23, 2024, a trademark application was filed for EOS SENOLYTI with the United States Patent and Trademark Office. The USPTO has given the EOS SENOLYTI trademark a serial number of 98919014. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 23, 2024. This trademark is owned by SENOTHERAPEUTIX, Inc.. The EOS SENOLYTI trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Anti-aging therapy; Anti-aging services; Anti-aging research; Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; Peptides for use in age-related diseases and cancer; Peptides for use in skin conditions; Anti-aging peptides; Peptides for use in prevention of radiation damage; Peptides for use in treatment of radiation damage; Peptides for use in prevention of radiation related diseases; Peptides for use in treatment of radiation related diseases; Peptides for use in treatment of obesity; Peptides for use in weight loss regimens, Peptides for use in treatment of...
eos senolyti

General Information


Serial Number98919014
Word MarkEOS SENOLYTI
Filing DateMonday, December 23, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, December 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the words Eos SENOLYTI in stylized black font ending with a partial lemniscate in blue.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAnti-aging therapy; Anti-aging services; Anti-aging research; Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders; Development of pharmaceutical preparations and medicines; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Testing, inspection, research, or development of pharmaceutical preparations for age therapy; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, and diagnostics; Peptides for use in age-related diseases and cancer; Peptides for use in skin conditions; Anti-aging peptides; Peptides for use in prevention of radiation damage; Peptides for use in treatment of radiation damage; Peptides for use in prevention of radiation related diseases; Peptides for use in treatment of radiation related diseases; Peptides for use in treatment of obesity; Peptides for use in weight loss regimens, Peptides for use in treatment of obesity in combination with other drugs; Biologic age scoring; Statistical scoring to determine a biologic age score of a patient; Medical services; Medical services, namely, anti-aging services; Medical services, namely, prevention and treatment of age-related disorders; Medical research services; Medical research services, namely, anti-aging services; Medical research services, namely, prevention and treatment of age-related disorders; Medical advisory services; Medical advisory services, namely, anti-aging services; Medical advisory services, namely, prevention and treatment of age-related disorders; Medical testing services; Medical testing services, namely, anti-aging services; Medical testing services, namely, prevention and treatment of age-related disorders; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Biopsy services; Biopsy services related to biologic age; Biopsy services related to biological age scoring; Biopsy services related to determining a number or percentage of senescent cells; Laboratory services; Laboratory services related to biologic age; Laboratory services related to biological age scoring; Laboratory services related to determining a number or percentage of senescent cells; Non-invasive testing; Non-invasive testing related to biologic age; Non-invasive testing related to biological age scoring; Non-invasive testing related to determining a number or percentage of senescent cells; Prevention of radiation damage; Treatment of radiation damage; Prevention of radiation related diseases; Treatment of radiation related diseases; Treatment of obesity; Weight loss regimens; Treatment of obesity in combination with other drugs

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 23, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSENOTHERAPEUTIX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events


Event DateEvent Description
Monday, December 23, 2024NEW APPLICATION ENTERED
Thursday, May 29, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, May 29, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED